The Utility of Bronchoalveolar Lavage (BAL) in Bronchiectasis: A Microbiological Concordance Study - Amsterdam 2025

Bronchiectasis: disease burden and microbiology

Chair(s): Sanjay Haresh Chotirmall, Tony De Soyza

Session type: Poster session

The Utility of Bronchoalveolar Lavage (BAL) in Bronchiectasis: A Microbiological Concordance Study

Martina Lo Casto

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Upper airway microbiome and clinical outcomes in bronchiectasis: the EMBARC-BRIDGE study

Hayoung Choi

Poster

Abstract

Microbial colonization of the lower respiratory tract in stable patients with non-CF bronchiectasis

Barney Isaac

Poster

Abstract

Bacterial and Mycobacterial Infections in Bronchiectasis in Algeria

Tarek Djenfi

Poster

Abstract

Indications and results of bronchoalveolar lavage in bronchiectasis patients

Alessandro De Angelis

Poster

Abstract

The Utility of Bronchoalveolar Lavage (BAL) in Bronchiectasis: A Microbiological Concordance Study

Martina Lo Casto

Poster

Abstract

Bronchiectasis in Italy: an analysis of the EMBARC Registry

Stefano Aliberti

Abstract

Aspergillus spp. Isolation in people with bronchiectasis: data from EMBARC

Mattia Nigro

Poster

Abstract

Nanopore Sequencing to characterize the Bronchiectasis Resistome preliminary results from the BRILLIANT study

Lucy Bidgood

Poster

Abstract

Respiratory pathogen clusters in patients with bronchiectasis: Data from the EMBARC registry.

Fiona Mosgrove

Poster

Abstract

Molecular characterisation of bronchiectasis infections in EMBARC-BRIDGE

Rebecca C Hull

Poster

Abstract

Role of mucus plugs in refractory asthma with bronchiectasis: focus on plug location

Natsuko Nomura

Poster

Abstract

Use of inhaled corticosteroids in patients with bronchiectasis and risk of acquiring Haemophilus influenzae infection: a retrospective cohort study

Dil Afrose

Poster

Abstract

Exacerbations among incident cases of bronchiectasis in Japan

Takanori Asakura

Poster

Abstract

Bacteriology in Swedish patients with idiopathic or post-infective bronchiectasis; early data from an EMBARC center.

Pia Ghosh

Poster

Abstract

Pseudomonas aeruginosa (PA) infection in Bronchiectasis:What predictors and impact?

Haifa Zaibi

Poster

Abstract

Outpatient parenteral antibiotic therapy (OPAT) in bronchiectasis care: a retrospective analysis of treatment outcomes and benefits.

Edel Lawless

Poster

Abstract

Mortality and exacerbations of carbapenem-resistant Pseudomonas aeruginosa isolation in hospitalized patients with bronchiectasis: a long-term retrospective cohort study

Jibo Sun

Poster

Abstract

History of tuberculosis exacerbates bronchiectasis outcomes linked to microbiome alteration

Yen-fu Chen

Poster

Abstract

Late Breaking Abstract - Phosphoglycerate Dehydrogenase-Mediated Serine Reprogramming Aggravates Macrophage Hyperinflammation in P. aeruginosa Pneumonia

Rong Chen

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}